MACK : Summary for Merrimack Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets close in 3 hrs 47 mins

Merrimack Pharmaceuticals, Inc. (MACK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.91-0.09 (-3.00%)
As of 12:13PM EST. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close3.00
Bid2.90 x 1600
Ask2.91 x 32900
Day's Range2.83 - 3.00
52 Week Range2.83 - 9.02
Avg. Volume4,140,655
Market Cap377.18M
PE Ratio (TTM)-2.12
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire5 days ago

    Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO

    CAMBRIDGE, Mass., Jan. 18, 2017 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (MACK) ("Merrimack" or the "Company") today announced that Richard Peters, M.D., Ph.D., has been appointed as the Company's President and Chief Executive Officer, effective February 6, 2017, at which time he will also be appointed to the Merrimack Board of Directors. Dr. Peters will join Merrimack from his current role at Sanofi Genzyme, where he serves as Senior Vice President and Head of Global Rare Diseases.  He replaces Gary Crocker, Chairman and Interim President and CEO, who guided the Company during the recent restructuring process and search for a permanent CEO and will remain Chairman of the Board.

  • Merrimack (MACK) Goes Uphill: Is a Turnaround Likely?
    Zacks6 days ago

    Merrimack (MACK) Goes Uphill: Is a Turnaround Likely?

    Shares of Merrimack Pharmaceuticals Inc (MACK) have increased 47.9% in the last twelve months as the company looks to restructure business.

  • 24/7 Wall St.6 days ago

    DryShips, Alcobra Sink into Tuesday’s 52-Week Low Club

    DryShips, Perrigo, Merrimack, and Alcobra post new 52-week lows Tuesday.